Minoxidil Response Test

What Is the Minoxidil Response Test

The Minoxidil Response Test (MRT) is a diagnostic hair test that measures whether you have sufficient SULT1A1 enzyme activity in your hair follicles to respond to minoxidil treatment. It was developed by DA Labs (Daniel Alain) after a decade of research into why minoxidil produces strong regrowth results for some people and virtually none for others.

The test addresses a fundamental problem: minoxidil is the only FDA-approved topical treatment for genetic hair loss, yet only 30 to 50 percent of users actually respond to it. For years, patients and dermatologists had no way to predict in advance whether minoxidil would work for a specific individual. The only option was to apply the treatment daily for six to nine months and wait. The minoxidil response test changes that equation by identifying the biological reason why minoxidil fails for some people before the waiting begins.

If you are using topical minoxidil as part of your telogen effluvium treatment and not seeing results, or if you are considering starting it, understanding whether you are likely to respond is directly relevant to your treatment decisions.

Why Minoxidil Does Not Work for Everyone

To understand why the minoxidil response test exists, you first need to understand how minoxidil actually works at a biological level, and where that process can break down.

Minoxidil Is a Prodrug

Minoxidil is not biologically active in the form you apply to your scalp or swallow as a pill. It is a prodrug, meaning it must be converted into its active form inside the body before it can do anything. The active form is called minoxidil sulfate. This conversion is what triggers the drug’s effects: lengthening the anagen (active growth) phase of the hair follicle cycle, increasing follicle size, and stimulating new hair production.

Without this conversion, minoxidil simply sits on your scalp or passes through your system without producing any meaningful effect on hair growth. You can apply it twice a day for a year and see nothing, not because minoxidil failed, but because the conversion never happened in your follicles.

The SULT1A1 Enzyme Is the Key Converter

The enzyme responsible for converting minoxidil into minoxidil sulfate in the hair follicle is called sulfotransferase 1A1, abbreviated as SULT1A1. This enzyme is found in the outer root sheath of hair follicles, and its activity level varies significantly between individuals due to genetic variation in the SULT1A1 gene.

People with high SULT1A1 activity convert minoxidil efficiently, producing the minoxidil sulfate needed to stimulate hair growth. People with low SULT1A1 activity cannot perform this conversion at a sufficient rate, regardless of how much minoxidil they apply. As published in a 2014 study in the Journal of the American Academy of Dermatology (Goren et al.), sulfotransferase enzyme activity in plucked hair follicles successfully predicted minoxidil response and ruled out non-responders with 95.9% accuracy.

SULT1A1 Gene Variants and What They Mean

The SULT1A1 gene has known variants that correspond to different levels of enzyme activity. The GG variant is associated with high activity and a stronger likelihood of responding to minoxidil. The GA variant represents intermediate activity, and the AA variant is associated with low activity and the lowest likelihood of response to topical minoxidil.

These variants explain the wide variability in clinical outcomes seen across minoxidil studies and in real-world use. Two people with identical degrees of hair loss applying identical amounts of minoxidil for identical durations can have completely different outcomes, purely based on their follicular SULT1A1 activity levels.

How the Minoxidil Response Test Works

The Sample Collection Process

The minoxidil response test is non-invasive and designed to be completed at home. The process involves plucking six strands of hair from the thinning area of the scalp using the provided sterilized tweezers. Each hair must include the follicle bulb at the root, since the SULT1A1 enzyme measurement requires analysis of follicular tissue, not just the hair shaft.

Before collecting the sample, it is important to avoid using products containing parabens, dandruff shampoos with zinc pyrithione, or any minoxidil-containing products for 24 hours. These can interfere with the enzyme assay. Sample collection and shipping must occur on the same day to preserve the specimen integrity.

What the Lab Analyzes

Once the lab receives the hair sample, it measures the enzymatic activity of SULT1A1 present in the outer root sheath cells of the plucked follicles using a proprietary assay. The test does not sequence your DNA or report genetic variants in the traditional sense. It directly measures the functional enzyme activity level, which is a more clinically actionable measurement than a genotype alone, since gene variants do not always correlate perfectly with actual enzyme output.

The test is processed in a CLIA-certified laboratory (Clinical Laboratory Improvement Amendments), which is the federal standard that governs clinical diagnostic testing accuracy and quality control in the United States.

Results Timeline

Results are typically delivered within six to eight weeks via the patient’s online account. The result report indicates whether you are predicted to be a responder or a non-responder to topical minoxidil, and in some cases provides guidance on next steps depending on your outcome.

Who Should Take the Minoxidil Response Test

The test is most useful for specific groups of people. It is not necessary or appropriate for everyone experiencing hair loss.

Situation	Is the Test Useful	Reason
Using minoxidil for 6+ months with no results	Yes	The test can confirm whether low SULT1A1 activity explains the lack of response
Considering starting minoxidil for androgenetic alopecia	Yes	Avoids committing 6-9 months to a treatment that may not work biologically
Hair loss from telogen effluvium only, no androgenetic alopecia	Limited	Minoxidil’s primary validated use is for genetic hair loss; TE-only patients may not benefit regardless of enzyme levels
Experiencing minoxidil shedding in first 1-3 months	Wait first	Initial shedding is a normal response and does not indicate non-responder status; evaluate results at 6 months
Considering oral minoxidil	Yes	Research shows SULT1A1 activity predicts response to oral minoxidil as well as topical
Hair loss from alopecia areata or scarring alopecia	No	These conditions involve different mechanisms; minoxidil is not the standard treatment for these types

Is the Test Relevant for Telogen Effluvium Patients

This is an important distinction. The minoxidil response test is validated for predicting response in androgenetic alopecia (genetic hair loss). If your hair loss is purely telogen effluvium with no underlying pattern hair loss component, the SULT1A1 test is less directly applicable, because TE does not involve the same follicular miniaturization that minoxidil targets.

However, many people experience both conditions simultaneously. Telogen effluvium is frequently triggered on top of underlying androgenetic alopecia, making the hair loss appear more severe. In these cases, minoxidil may be prescribed to address the genetic component, and the response test would be relevant. If you are unsure whether you have androgenetic alopecia alongside your TE, a dermatologist who specializes in hair loss can assess your scalp and diagnose whether both conditions are present.

The Clinical Evidence Behind Minoxidil Response Testing

Supporting Research

The scientific basis for minoxidil response testing is grounded in peer-reviewed research, though the evidence base is still developing and the studies are not large-scale.

A landmark 2014 study published in the Journal of Drugs in Dermatology (Goren et al.) confirmed the clinical utility of a sulfotransferase enzyme assay in successfully ruling out 95.9% of non-responders to topical minoxidil in androgenetic alopecia. This is the primary clinical validation cited for the test’s accuracy.

A 2021 study published in the Journal of the European Academy of Dermatology and Venereology extended this finding to oral minoxidil, demonstrating that SULT1A1 genetic variants predicted response to oral minoxidil treatment in women with female pattern hair loss. This established that the same enzyme pathway governs response to both topical and oral forms of the drug.

A 2022 review published in PMC (Ramos et al.) confirmed that SULT1A1 expression in the scalp varies significantly between individuals and that this variation explains the variable clinical response to topical minoxidil treatment.

Limitations and Honest Caveats

Clinical fairness requires acknowledging the limitations of the current evidence.

The key studies supporting SULT1A1 testing have relatively small sample sizes. The most cited validation study involved a limited cohort, and critics have noted that several of the studies were published in journals with lower impact factors rather than top-tier dermatology publications.

The test reports a sensitivity of approximately 100% (meaning it correctly identifies almost all non-responders) but a specificity of approximately 75% (meaning roughly one in four people predicted to respond may still not see results). This asymmetry is by design: the test is optimized to ensure non-responders are not missed, at the cost of occasionally flagging some potential responders as uncertain.

Larger, fully independent, prospective clinical trials would strengthen confidence in the test’s predictive value. The test is a useful clinical tool but should be interpreted as one piece of information rather than a definitive verdict, and ideally reviewed in consultation with a dermatologist.

Understanding Your Results

If You Test Positive (Responder)

A positive result means your SULT1A1 enzyme activity is at a sufficient level to convert minoxidil into its active form. This indicates you are biologically positioned to respond to minoxidil treatment for androgenetic alopecia.

A positive result does not guarantee visible regrowth. Results from minoxidil typically require six to nine months of consistent daily use before they become apparent. Early shedding in the first one to three months is normal and does not indicate failure. Adherence to the dosing schedule and combining minoxidil with other evidence-based treatments where appropriate will maximize your outcomes.

If You Test Negative (Non-Responder)

A negative result means your SULT1A1 enzyme activity is too low to activate minoxidil effectively. Using standard topical minoxidil at this level is unlikely to produce meaningful hair regrowth, regardless of dose or duration.

This is not the end of the road. Several options exist for people with low SULT1A1 activity.

• SULT1A1 enzyme boosters: DA Labs has developed a topical enzyme booster that has been shown in a randomized, blinded, placebo-controlled trial to increase SULT1A1 activity in hair follicles. Pairing an enzyme booster with minoxidil may convert a non-responder into a functional responder. The published trial showed meaningful improvement over minoxidil alone in treated patients.
• Topical tretinoin: Research has shown that topical tretinoin influences the expression of follicular sulfotransferase. In one study, 43% of subjects initially predicted to be non-responders were converted to responders following five days of topical tretinoin application. Tretinoin is commonly used in combination with minoxidil for this reason.
• Oral minoxidil: Oral minoxidil undergoes first-pass metabolism in the liver, where sulfotransferase activity is much higher than in the scalp. This means that for some patients with low scalp SULT1A1, oral minoxidil may be more effective than topical. However, oral minoxidil is not FDA-approved for hair loss and carries systemic side effects that require physician oversight.
• Alternative treatments: Finasteride and dutasteride (for androgenetic alopecia), low-level laser therapy, platelet-rich plasma (PRP), and hair transplant surgery do not depend on SULT1A1 activity and remain viable options regardless of your test result.

Oral Minoxidil and the Response Test

An important and often overlooked finding is that SULT1A1 activity also predicts response to oral minoxidil, not just topical. This might seem counterintuitive: if oral minoxidil is activated in the liver (where sulfotransferase activity is high regardless of scalp levels), why would scalp SULT1A1 matter?

Research published in 2020 (Goren et al., Journal of the European Academy of Dermatology and Venereology) established that oral minoxidil’s activation for hair regrowth specifically occurs in the scalp follicle, not the liver. The liver activation produces systemic effects including blood pressure effects, but the hair regrowth mechanism requires local follicular sulfotransferase activity. This means SULT1A1 levels in the scalp remain predictive of hair regrowth response even for oral minoxidil, making the test relevant for patients considering either route.

Where to Get the Minoxidil Response Test

The Minoxidil Response Test is commercially available through DA Labs (dalabs360.com) and through Daniel Alain’s website (danielalain.com). As of the most recent public pricing, the test is priced at approximately $139. It is available for both men and women.

Geographic availability is currently limited to the United States, and is not available in Hawaii, Idaho, New York, Puerto Rico, Rhode Island, Vermont, and the Virgin Islands.

The test is not currently available through standard clinical laboratories or standard dermatology offices, though some hair loss clinics may offer equivalent enzyme activity testing as part of a comprehensive assessment. Clinics offering the TrichoTest, a broader genetic hair loss panel that includes SULT1A1 analysis alongside 48 other genetic variations related to hair loss and treatment response, provide an alternative route to similar information.

Before ordering, consider discussing the test with your dermatologist. They can help you interpret the results in the context of your specific type of hair loss, your overall health history, and the full range of treatment options available to you.

Minoxidil Response Testing and Telogen Effluvium

If you are managing telogen effluvium and your dermatologist has recommended minoxidil as part of your treatment plan, the minoxidil response test is worth discussing before you begin. There are a few important considerations specific to TE patients.

First, telogen effluvium is a temporary condition and often resolves on its own once the triggering stressor is addressed. If your hair loss is purely TE without an androgenetic component, minoxidil may not be the most appropriate intervention regardless of your enzyme levels.

Second, if you do have underlying androgenetic alopecia that was unmasked or worsened by a TE episode, minoxidil may be appropriate for the genetic component. In this case, knowing your SULT1A1 status before investing months in a treatment is a reasonable and practical step.

Third, many patients recovering from TE are also nutritionally depleted, particularly in iron, vitamin D, and zinc. Correcting these deficiencies is the primary treatment for TE and should happen regardless of minoxidil decisions. You can read more about the role of nutritional deficiencies in our complete TE treatment guide.

Minoxidil Response Test FAQ

What is the minoxidil response test?

The minoxidil response test (MRT) is an at-home diagnostic test that measures SULT1A1 enzyme activity in plucked hair follicles to predict whether a person will respond to minoxidil treatment. It was developed by DA Labs after research identified SULT1A1 as the key enzyme responsible for converting minoxidil into its active form inside the hair follicle.

How accurate is the minoxidil response test?

Published clinical studies report 95.9% accuracy in ruling out non-responders, with a test sensitivity of approximately 100% and a specificity of approximately 75%. This means the test is very reliable at confirming non-responder status, but a positive result does not guarantee regrowth since roughly one in four predicted responders may still not see significant results. Consulting a dermatologist to interpret results in the context of your full clinical picture is advisable.

What is SULT1A1 and why does it matter for minoxidil?

SULT1A1 (sulfotransferase 1A1) is an enzyme found in the outer root sheath of hair follicles. Its role is to convert minoxidil from its inactive prodrug form into minoxidil sulfate, the active compound that stimulates hair growth. People with insufficient SULT1A1 activity cannot complete this conversion, meaning minoxidil remains inactive in their follicles regardless of how long or how much they use it.

Does the test work for oral minoxidil too?

Yes. Research has established that SULT1A1 activity in the scalp predicts response to oral minoxidil as well as topical minoxidil, because hair regrowth from oral minoxidil is activated locally in the scalp follicle rather than through liver metabolism. The same test result applies to both routes of administration.

What happens if I am a non-responder?

A negative result does not mean you cannot treat your hair loss. Options for non-responders include using a topical SULT1A1 enzyme booster alongside minoxidil, applying topical tretinoin which has been shown to upregulate scalp sulfotransferase activity, trying oral minoxidil under physician supervision, or pursuing alternative treatments such as finasteride, PRP, low-level laser therapy, or hair transplantation that do not rely on SULT1A1 activity.

Is the minoxidil response test useful for telogen effluvium?

The test is validated specifically for androgenetic alopecia (genetic hair loss) and is not directly applicable to pure telogen effluvium cases. However, if a person has both TE and underlying androgenetic alopecia, the test is relevant for the genetic component. A dermatologist can help determine whether both conditions are present.

How long does the minoxidil response test take?

Results are typically returned within six to eight weeks from the date the lab receives the sample. Sample collection and return shipping can be completed the same day the kit is received. Registration must also be completed on the day of sample collection.

Can I take the test if I am already using minoxidil?

You should stop using all minoxidil-containing products for at least 24 hours before collecting your sample. Minoxidil can interfere with the enzyme activity assay. Also avoid products with parabens and dandruff shampoos containing zinc pyrithione for the same period before sample collection.

Is the minoxidil response test available outside the United States?

Currently the test is only available in the United States, and is not available in Hawaii, Idaho, New York, Puerto Rico, Rhode Island, Vermont, and the Virgin Islands. International availability is limited; some clinics outside the US offer alternative sulfotransferase enzyme testing as part of broader hair loss genetic panels such as the TrichoTest.